The SAMRIDH Healthcare Blended Finance Facility, supported by the United States Agency for International Development (USAID) and implemented by IPE Global, has committed Rs 1.5 crore (USD 1,88,529) to Clensta to enhance access to affordable health and hygiene products in healthcare facilities and other touchpoints in tier 2 and 3 regions, and in vulnerable pockets of tier 1 cities.
Clensta is an start-up incubated at IIT Delhi. Their waterless technology enables cleansing and disinfection of the entire body without water.
The partnership will enable Clensta to expand its sales force and strengthen the distribution channels to make its hygiene products available to over 2,100 nursing homes, clinics, pharmacies, hospitals and other touchpoints such as direct purchases by central government agencies and PSUs thereby reducing healthcare-acquired infections and democratising the personal hygiene index across tier 2 and tier 3 cities in India.
Himanshu Sikka, Project Director, SAMRIDH and Chief Strategy and Diversification Officer, IPE Global said, “At SAMRIDH, we are committed to support scale-up of innovations and market solutions to improve the health and well-being of vulnerable communities. Through our partnership with Clensta, we aim to reduce the risk factor of patients in tier 2 and 3 cities by enabling healthcare facilities to access affordable waterless hygiene and medicated products. Mainstreaming Clensta’s waterless technology can be a game changer in these locations where acute water shortages have been a long-standing challenge.”
In our mission to enhance access to innovative sustainable products for underserved communities, we are excited to support Clensta in making their products available in tier 2 and 3 cities at affordable prices by establishing direct distribution channels. We are hopeful that the waterless technology innovation will be a game changer for maintaining hygiene standards at medical facilities in these locations with acute water shortages.”
Puneet Gupta, Founder, Clensta said, “The purpose behind our healthcare portfolio: waterless and COVID protection products has always been a thoughtful one, to ensure we protect as many individuals as possible from the same challenges I have faced or seen people face in my journey. This collaboration will help us solve problems on a wider scale. The waterless portfolio will ensure that there are very low chances of hospital-acquired infections in vulnerable areas, thus taking us a step further to achieving a better world. The validation from supporting SAMRIDH also proves that our healthcare portfolio is truly innovative; this step is crucial as it will help us serve more and more people through other partnerships.”
